Functional foods and nutraceuticals

01Overview and value chain

Markers: [EC: EU Health Claims Regulation (EC) 1924/2006 — functional-food claim substantiation | OECD: Food systems | Regulator: FDA (USA), EFSA (EU)]

Functional foods and nutraceuticals cover food and supplement products engineered to deliver a specific, substantiated health benefit beyond basic nutrition — immunity, healthy aging, gut health — rather than a generic wellness claim. The category’s center of gravity is shifting from one-size-fits-all supplements toward personalization: Danone’s Singapore D-Lab is applying AI and digital tools to healthy-ageing nutrition and screening, and industry surveys identify a broader “MegaTrend” shift from generic offerings to nutrition that responds to an individual’s own data. ADM is positioning postbiotics specifically as a next-generation ingredient for healthy aging across mood, sleep and metabolism, while Amway’s Nutrilite brand continues to build immunity-support formulations that combine traditional herbal actives (turmeric, licorice) with vitamin C. Consolidation is already reshaping the challenger-brand tier: Hindustan Unilever agreed to fully acquire India’s OZiva, a clean-label protein and women’s-health supplement brand, for roughly $90 million in February 2026.

Key directions of functional foods and nutraceuticals:

1. Personalized nutrition platforms (Personalized Nutrition Platforms): AI- and data-driven tools (nutrigenetics, gut-microbiome profiling) tailoring a functional-food or supplement recommendation to an individual.
2. Postbiotic and next-generation biotic ingredients (Postbiotic Ingredients): non-living microbial-derived ingredients positioned for specific outcomes (healthy aging, mood, sleep, metabolism) beyond classic probiotics.
3. Traditional-herbal/vitamin combination formulations (Traditional- Herbal/Vitamin Combination Formulations): blending long-established botanicals with vitamins into a single immunity- or wellness-targeted product.
4. Challenger clean-label brand consolidation (Challenger Clean-Label Brand Consolidation): large incumbents acquiring fast-growing, digitally native supplement brands rather than building the same positioning in-house.

Sectoral value chain

[health-benefit target] ──> [ingredient/formulation R&D] ──> [claim substantiation] ──> [product formulation]
                                                                     │
                                                             (regulatory
                                                              claim review)
                                                                     │
                                                                     ▼
[retail/DTC sale] <─── [brand positioning] <────────────────────────┘

Value chain levels

Cross-cutting technologies of the sector:

• Nutrigenetic/microbiome personalization (Nutrigenetic/Microbiome Personalization): integrating an individual’s genetic or gut-microbiome data into a product or shopping recommendation.
• Postbiotic ingredient standardization (Postbiotic Ingredient Standardization): producing non-living, microbial-derived ingredients with consistent, claims-ready composition.
• Health-claim substantiation pipelines (Health-Claim Substantiation Pipelines): structured clinical/scientific evidence generation designed specifically to clear a regulator’s claim-approval bar.

02US

The US hosts both a long-established herbal-nutraceutical brand and a global ingredient supplier pivoting toward next-generation biotic ingredients.

postbiotic ingredient innovation, herbal/vitamin immunity formulations, healthy-aging positioning

• ADM: positions postbiotics as a next-generation biotic ingredient for healthy-aging functional foods, targeting mood, sleep and metabolism outcomes alongside its broader protein-ingredient innovation.
• Amway Nutrilite: builds immunity-support formulations combining traditional herbal actives (turmeric, licorice, Amalaki/Vibhitaki/Haritaki) with vitamin C, alongside concentrated fruit-and-vegetable phytonutrient products.

03CN

Public information on a dedicated Chinese functional-foods/nutraceuticals originator distinct from the region’s broader supplement manufacturing base was not confirmed in this pass; the section stays at the policy level.

functional-food market research activity, nanoencapsulation research, no confirmed flagship originator

• Active market-research interest: Chinese industry research reports track functional-food market size and growth forecasts, reflecting significant commercial interest in the category.
• Nanoencapsulation research base: academic work on nanoencapsulation of nutraceuticals for improved stability and bioavailability is active, ahead of a confirmed flagship commercial originator in this specific pass.
• No confirmed flagship originator: a Chinese company matching the personalization/postbiotic positioning seen in the US/EU leaders was not confirmed via live sources in this pass.

04EU

The EU is applying AI and digital tools to personalize functional nutrition around specific life stages, anchored by a health-claim regulation that gates every functional-food claim made in the market.

AI-driven personalized nutrition, healthy-ageing screening tools, EU health-claim substantiation

• Danone Nutricia Research: its Singapore D-Lab applies AI and digital capabilities to develop health-screening tools and nutrition solutions supporting healthy ageing, part of a broader industry shift toward nutrigenetics- and microbiome-informed personalization.
• Personalization as a stated industry MegaTrend: industry trend analysis identifies the shift from generic functional-nutrition offerings to individually responsive products as a defining 2026 direction.
• EU Regulation (EC) 1924/2006: requires every functional-food health claim to be scientifically substantiated and formally authorized before use in EU marketing.

05Leading companies and research institutes

06Tech stack and innovations

The stack combines personalization data with claims-grade ingredient science.

1. AI-driven nutrition personalization (AI-Driven Nutrition Personalization):
   • digital tools integrate nutrigenetic and gut-microbiome data to tailor a nutrition or shopping recommendation to an individual.
   • case: Danone’s D-Lab applies AI and digital capabilities specifically to healthy-ageing screening and nutrition solutions.
2. Postbiotic ingredient engineering (Postbiotic Ingredient Engineering):
   • non-living, microbial-derived ingredients are standardized and positioned for specific outcomes beyond classic live-probiotic claims.
   • case: ADM backs postbiotics specifically to drive healthy-aging innovation across mood, sleep and metabolism claims.
3. Challenger-brand claims positioning (Challenger-Brand Claims Positioning):
   • digitally native brands build a clean-label, claims-specific position (protein, women’s health) that becomes an acquisition target for incumbents.
   • case: Hindustan Unilever’s ~$90 million acquisition of OZiva brought a clean-label protein and women’s-health brand directly into an incumbent’s portfolio.

07Value chains and production pipelines

Industrial pipeline of a claims-substantiated functional food (EU Health Claims Regulation)

┌───────────────────────────┐      ┌───────────────────────────┐
│ 1. Health-benefit target  │ ───> │ 2. Ingredient/formulation R&D│
└───────────────────────────┘      └───────────────────────────┘
                                                 │
                                                 ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 4. Product formulation    │ <─── │ 3. Claim substantiation   │
└───────────────────────────┘      └───────────────────────────┘
              │
              ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 5. Regulatory claim review│ ───> │ 6. Retail/DTC launch      │
└───────────────────────────┘      └───────────────────────────┘

Stage 1: Health-benefit target

A specific outcome — immunity, healthy aging, gut health, women’s health — is selected as the product’s target claim.

Stage 2: Ingredient/formulation R&D

Active ingredients (postbiotics, herbal actives, vitamins) are selected or developed to address the target outcome.

Stage 3: Claim substantiation

Clinical or scientific evidence is generated to support the specific health claim being made.

Stage 4: Product formulation

The substantiated ingredient is finalized into a food, drink or supplement product format.

Stage 5: Regulatory claim review

The health claim clears FDA review or EU Regulation 1924/2006 authorization before it can be marketed.

Stage 6: Retail/DTC launch

The product reaches consumers through retail or direct-to-consumer channels, with brand positioning increasingly a driver of acquisition activity in the category.